Results 61 to 70 of about 1,273,243 (249)

LE CORPS FÉMININ ET SES FLUCTUATIONS DANS LES FLEURS DU MAL ET PETITS POÈMES EN PROSE DE CHARLES BAUDELAIRE [PDF]

open access: yesStudii si Cercetari Filologice: Seria Limbi Romanice, 2020
Animée d’un souffle splénétique, l’œuvre baudelairienne raconte le corps féminin dans ses multiples fluctuations, partant du corps idéalisé pour sa beauté insolite, jusqu’à sa désacralisation par la souillure du désir charnel et l’emprise du temps.
Saadia RAHALI
doaj  

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Dekadentni duh u „Panu i Siringi” Žila Laforga

open access: yesFilolog, 2015
Kao književni pravac dekadencija se javlja u 19. stoljeću u Francuskoj, stvarajući svoju školu i krug pristalica usmjerenih protiv građanske stvarnosti i njenog morala.
Frano Vrančić
doaj   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

The Tertiary sequence of Varkala coastal cliffs, southwestern India: An ideal site for Global Geopark

open access: diamond, 2022
K.S. Sajinkumar   +7 more
openalex   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

open access: yesMolecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad   +12 more
wiley   +1 more source

Hesitant intuitionistic fuzzy ideals of $\Gamma$-semirings

open access: yesJournal of New Results in Science, 2020
In this paper, we have definedhesitant intuitionistic fuzzy ideals, hesitantintuitionistic fuzzybi-ideals and hesitant intuitionistic fuzzy quasi-ideals of a $\Gamma$-semiring and obtain some of their related properties.
Debabrata Mandal
doaj  

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy